Today, Bryden Teich commented about whether CTXS-Q, BIP.UN-T, CVS-N, CNQ-T, SHOP-T, BAM.A-T, ABX-T, ENGH-T, DBX-Q, BLDP-T, ALA-T, BEI.UN-T, BPY.UN-T, NFI-T, HUM-N, CJT-T, WBA-Q, SU-T, ARX-T, RSI-T are stocks to buy or sell.
He used to own it to get exposure to Canadian natural gas. Assets and management are superb, and pays a fine dividend. However, at the start of March, he changed his outlook given how tough a sector energy was and gas demand was uncertain. He sold all his energy stocks and put his money into CNQ. Arc is still a good company. If you hold, be patient. When energy improves, so will Arc's stock.
Suncor vs. CNQ Both great Canadian energy stocks. He has owned Suncor and currently owns CNQ as his only energy stock. CNQ maintained its dividend throughout the lockdown, while he believes Suncor lowered theirs to protect their balance sheet. He likes CNQ in energy---you still get a nice yield. Suncor and CNQ will do well long term. Suncor will do well if the energy space improves. He owns 3.5-4% energy on the low side, but you don't want to own too much or too little energy. About two years ago, SU's refining assets were doing really well and got a premium valuations, so maybe that's why the stock has unwound recently.
He has owned CVS instead in the past. This and WBA have been hit hard in recent years from a lingering concern over pressure on drug prices in the U.S. So, both have expanded into drug distribution, not just drug retail. The multiple that the market will pay for either has compressed. So, he prefers other stocks in this space, like Loblaws (which owns Shoppers Drug Mart) Drug. Traditionally, drug retailing is a stable business, but in the U.S. the pricing issue remains an overhang.